ZAS Corporation is proud to collaborate with the Rheumatology Department of BIRDEM General Hospital to introduce three world-class biosimilar therapies from Celltrion Healthcare, Korea—Yuflyma® (adalimumab), Truxima® (rituximab), and Remsima® (infliximab).
The initiative was formally marked at a recent CME event, where Dr. Sabrina Yesmin, Associate Professor & Head of the Rheumatology Department, shared her expert insights on the role of biosimilars in enhancing treatment accessibility and improving patient outcomes.
This milestone represents a significant step forward in making advanced, evidence-based rheumatology care more affordable and accessible in Bangladesh, aligning global innovation with local healthcare needs.
More Releases
ZAS Industries Participates in the 18th International Surgical Congress Organized by SOSB
https://www.facebook.com/share/v/16eNwBVMPS
ZAS Industries proudly participated in the 18th International...
ZAS Corporation Participates in the 17th Annual Scientific Conference 2025 of the Bangladesh Rheumatology Society
https://www.facebook.com/share/v/17e8zQHb5f
ZAS Corporation proudly participated in the 17th Annual...
ZAS Corporation Ltd. Participates in the 1st International Meeting on Regional Anaesthesia Bangladesh 2025
https://www.facebook.com/share/v/1C5bnsssbo
ZAS Corporation Ltd. proudly participated in the 1st International...
ZAS Corporation Ltd. Participates in the 8th National Scientific Conference 2025 on Paediatric Pulmonology
https://www.facebook.com/share/v/17zY1whE5t
ZAS Corporation Ltd. proudly participated in the 8th National...
ZAS Corporation Participates in the 11th International Neuro Conference 2025
https://www.facebook.com/share/v/1Acg8pW9WC
ZAS Corporation proudly participated in the 11th International...
ZAS Corporation Showcases Oncology Advancements at MOSB Congress 2025
https://www.facebook.com/share/v/1Hb4ptLXBf
ZAS Corporation proudly participated in MOSB Congress 2025,...
ZAS Corporation Participates in EHA–HSB Hematology Tutorial 2025, Advancing Hematology Care in Bangladesh
https://www.facebook.com/share/v/185VLNiSxH
ZAS Corporation was honored to participate in the EHA–HSB...
ZAS Corporation Participates in Anesthesia Day 2025, Strengthening Commitment to Patient Care
https://www.facebook.com/share/v/1a9fjSn8TH
ZAS Corporation was privileged to participate in the Anesthesia...
ZAS Corporation Launches DECA® Surgical Glove Series, A New Era in Surgical Excellence
ZAS Corporation proudly announces the official launch of its DECA® series of sterile surgical gloves,...
ZAS Corporation Strengthens Partnership with Celltrion Korea
ZAS Corporation recently held a strategic business overview meeting with its esteemed global partner,...